Related Experiment Videos
NmCV-5 meningococcal vaccine: Neisseria meningitidis' nemesis?
Marie-Pierre Preziosi1, Brian Greenwood2
1WHO, Geneva CH1211, Switzerland.
The Lancet. Infectious Diseases
|August 19, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Potential Use of Neisseria meningitidis Serogroup B Vaccines to Prevent Neisseria gonorrhoeae Infection: Epidemiological Considerations.
Journal of the International AIDS Society·2026
Five-year immunogenicity and safety follow-up of the PREVAC randomized Trial of Vaccines for Zaire Ebola Virus Disease.
medRxiv : the preprint server for health sciences·2026
Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trial.
PLoS neglected tropical diseases·2026
The risk of mpox false positive results in high transmission settings: evidence from a multi-site observational study in DR Congo.
The Lancet. Infectious diseases·2026
Is a tiered classification framework needed for sexually transmitted infections?
The Lancet. Infectious diseases·2026
Nucleic acid amplification testing and genome sequencing for WHO priority viruses in Africa: a scoping review.
The Lancet. Infectious diseases·2026
Ring and community vaccination for Bundibugyo virus outbreak response: a stochastic network modelling study.
The Lancet. Infectious diseases·2026